Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial
Bear, The only difference I see between the new PK study and the New Zealand PK study is that the new one will be with people on dialysis where the New Zealand one was with stage 4 patients not on dialysis.